Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Neurofibroma
ADR ID BADD_A03041
ADR Hierarchy
17      Nervous system disorders
17.18      Nervous system neoplasms benign
17.18.01      Nervous system neoplasms benign NEC
17.18.01.004      Neurofibroma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.09      Nervous system neoplasms benign
16.09.01      Nervous system neoplasms benign NEC
16.09.01.004      Neurofibroma
Description A moderately firm, benign, encapsulated tumor resulting from proliferation of SCHWANN CELLS and FIBROBLASTS that includes portions of nerve fibers. The tumors usually develop along peripheral or cranial nerves and are a central feature of NEUROFIBROMATOSIS 1, where they may occur intracranially or involve spinal roots. Pathologic features include fusiform enlargement of the involved nerve. Microscopic examination reveals a disorganized and loose cellular pattern with elongated nuclei intermixed with fibrous strands. (From Adams et al., Principles of Neurology, 6th ed, p1016) [MeSH]
MedDRA Code 10029267
MeSH ID D009455; D018318
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Neurofibroma | Plexiform neurofibroma | Neurofibromas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01136Imatinib0.000112%
BADD_D01366Medroxyprogesterone acetate--
The 1th Page    1    Total 1 Pages